Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled.

Fung KY, Nice E, Priebe I, Belobrajdic D, Phatak A, Purins L, Tabor B, Pompeia C, Lockett T, Adams TE, Burgess A, Cosgrove L.

World J Gastroenterol. 2014 Jan 28;20(4):888-98. doi: 10.3748/wjg.v20.i4.888. Review.

2.

Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.

Ostendorff HP, Awad A, Braunschweiger KI, Liu Z, Wan Z, Rothschild KJ, Lim MJ.

J Immunol Methods. 2013 Dec 31;400-401:58-69. doi: 10.1016/j.jim.2013.09.013. Epub 2013 Oct 24.

3.

Serum tests for colorectal cancer screening.

Creeden J, Junker F, Vogel-Ziebolz S, Rex D.

Mol Diagn Ther. 2011 Jun 1;15(3):129-41. doi: 10.2165/11591300-000000000-00000. Review.

PMID:
21766904
4.

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR.

Clin Biochem. 2013 Apr;46(6):466-79. doi: 10.1016/j.clinbiochem.2012.10.039. Epub 2012 Nov 13. Review.

PMID:
23159294
5.

Promoter CpG island methylation markers in colorectal cancer: the road ahead.

Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM.

Epigenomics. 2012 Apr;4(2):179-94. doi: 10.2217/epi.12.9. Review.

PMID:
22449189
6.

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.

PLoS One. 2012;7(9):e44398. doi: 10.1371/journal.pone.0044398. Epub 2012 Sep 6.

7.

The discovery and validation of colorectal cancer biomarkers.

Ang CS, Phung J, Nice EC.

Biomed Chromatogr. 2011 Jan;25(1-2):82-99. doi: 10.1002/bmc.1528. Epub 2010 Nov 5. Review.

PMID:
21058408
8.

Biomarkers for early detection of colorectal cancer and polyps: systematic review.

Shah R, Jones E, Vidart V, Kuppen PJ, Conti JA, Francis NK.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1712-28. doi: 10.1158/1055-9965.EPI-14-0412. Epub 2014 Jul 8. Review.

9.

Novel serum nucleosomics biomarkers for the detection of colorectal cancer.

Holdenrieder S, Dharuman Y, Standop J, Trimpop N, Herzog M, Hettwer K, Simon K, Uhlig S, Micallef J.

Anticancer Res. 2014 May;34(5):2357-62.

PMID:
24778043
10.

Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.

Thorsen SB, Lundberg M, Villablanca A, Christensen SL, Belling KC, Nielsen BS, Knowles M, Gee N, Nielsen HJ, Brünner N, Christensen IJ, Fredriksson S, Stenvang J, Assarsson E.

J Transl Med. 2013 Oct 10;11:253. doi: 10.1186/1479-5876-11-253.

11.

Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).

Hammoudi A, Song F, Reed KR, Jenkins RE, Meniel VS, Watson AJ, Pritchard DM, Clarke AR, Jenkins JR.

Biochem Biophys Res Commun. 2013 Oct 25;440(3):364-70. doi: 10.1016/j.bbrc.2013.08.076. Epub 2013 Aug 31.

PMID:
23998936
12.

An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.

Ma Y, Zhang P, Wang F, Liu W, Yang J, Qin H.

Ann Surg. 2012 Apr;255(4):720-30. doi: 10.1097/SLA.0b013e31824a9a8b.

PMID:
22395091
13.

Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.

Chen H, Werner S, Tao S, Zörnig I, Brenner H.

Cancer Lett. 2014 May 1;346(2):178-87. doi: 10.1016/j.canlet.2014.01.007. Epub 2014 Jan 22. Review.

PMID:
24462820
14.

Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.

Ma H, Chen G, Guo M.

Proteomics Clin Appl. 2016 Apr;10(4):503-15. doi: 10.1002/prca.201500082. Epub 2016 Feb 3. Review.

PMID:
26616366
15.

Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.

Findeisen P, Röckel M, Nees M, Röder C, Kienle P, Von Knebel Doeberitz M, Kalthoff H, Neumaier M.

Int J Oncol. 2008 Nov;33(5):1001-10.

PMID:
18949363
16.

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH.

Oncol Rep. 2010 Jul;24(1):57-64.

PMID:
20514444
17.

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Wang LG, Gu J.

Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.

PMID:
22018950
18.

Biomarkers for colorectal cancer.

Tanaka T, Tanaka M, Tanaka T, Ishigamori R.

Int J Mol Sci. 2010 Sep 13;11(9):3209-25. doi: 10.3390/ijms11093209. Review.

19.

A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.

Zou M, Zhang PJ, Wen XY, Chen L, Tian YP, Wang Y.

Methods. 2015 Jul 15;83:3-17. doi: 10.1016/j.ymeth.2015.05.011. Epub 2015 May 15.

PMID:
25980368
20.

Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.

Wang K, Huang C, Nice EC.

Expert Rev Proteomics. 2014 Apr;11(2):179-205. doi: 10.1586/14789450.2014.894466. Epub 2014 Mar 10. Review.

PMID:
24611605

Supplemental Content

Support Center